Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China flag China · Delayed Price · Currency is CNY
26.52
-1.10 (-3.98%)
Sep 10, 2026, 3:04 PM CST

SHE:301130 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
207.96234.84256.41225.49255.47285.66
Revenue Growth
-18.69%-8.41%13.71%-11.73%-10.57%-0.23%
Gross Profit
152.74177.8195.24179.97208.05238.68
Operating Income
-2.4815.737.5726.7736.2848.25
Net Income
5.8821.940.2750.540.7252.02
Earnings Per Share
0.080.290.520.630.530.86
EPS Growth
-85.67%-44.66%-17.23%18.84%-38.73%4.58%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceuticals
234.4255.25225.14255.4285.14
Unallocated Other Business
0.441.160.350.070.51
Total
234.84256.41225.49255.47285.66

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
223.77236.46275.65550.28616.08215.2
Total Debt
39.9811.6110.20.32--
Net Cash (Debt)
183.79224.85265.46549.96616.08215.2
Net Cash Growth
-26.49%-15.30%-51.73%-10.73%186.28%22.20%
Net Cash Per Share
2.412.943.416.817.963.55

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
42.6248.6254.2454.3967.2359.01
Capital Expenditures
-64.14-66.06-134.97-123.17-54.4-21.18
Free Cash Flow
-21.52-17.44-80.73-68.7912.8337.83
Free Cash Flow Growth
-----66.09%-24.39%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
73.45%75.71%76.15%79.81%81.44%83.55%
Operating Margin
-1.19%6.69%14.65%11.87%14.20%16.89%
Pretax Margin
1.01%8.94%18.14%25.86%19.74%20.73%
Profit Margin
2.83%9.32%15.71%22.40%15.94%18.21%
FCF Margin
-10.35%-7.43%-31.49%-30.51%5.02%13.24%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1450.1450.2600.2600.1600.130
Dividend Per Share Growth
-44.23%-44.23%0%62.50%23.08%-
Dividend Yield
0.53%0.51%1.00%0.96%0.57%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
354.4699.6949.9044.6157.29-
P/FCF Ratio
----181.84-
PS Ratio
10.039.307.849.999.13-